| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
ABO-inkompatible Nierentransplantation – warum und wie? - ABO-incompatible renal transplantation – why and how?
|
Hugo, C.
|
|
2008
|
47 |
9 |
p. 1074-1078
|
article
|
| 2 |
Aktive Immuntherapie urologischer Tumoren und tumorbedingte Immunsuppression - Active immunotherapy of urologic malignancies and tumor-mediated immunosuppression
|
Kübler, H.
|
|
2008
|
47 |
9 |
p. 1122-1127
|
article
|
| 3 |
Berufspolitik BDU
|
|
|
2008
|
47 |
9 |
p. 1269-1284
|
article
|
| 4 |
Bioartifizielles autologes Urothel etabliert aus Spülungen der Harnblase - Bioartificial urothelium generated from bladder washings
|
Feil, G.
|
|
2008
|
47 |
9 |
p. 1091-1096
|
article
|
| 5 |
CpG-Insel-Hypermethylierung der DNA - CpG island hypermethylation of the DNA
|
Bastian, P.J.
|
|
2008
|
47 |
9 |
p. 1205-1207
|
article
|
| 6 |
Das Berufskrankheitenverfahren bei urologischen Erkrankungen - Procedures for determining occupational diseases in cases of urological disorders
|
Schöps, W.
|
|
2008
|
47 |
9 |
p. 1112-1116
|
article
|
| 7 |
Das Transitionalzellkarzinom der Harnblase - Transitional cell carcinoma of the bladder
|
Hegele, A.
|
|
2008
|
47 |
9 |
p. 1137-1140
|
article
|
| 8 |
Deutscher Forschungsverbund Blasenkarzinom e.V. - German Association for Bladder Cancer Research
|
Retz, M.
|
|
2008
|
47 |
9 |
p. 1141-1144
|
article
|
| 9 |
Deutsches Netzwerk Nierenzelltumoren - The German Renal Cell Tumor Network
|
Junker, K.
|
|
2008
|
47 |
9 |
p. 1171-1172
|
article
|
| 10 |
Die funktionelle retrourethrale Schlinge - Functional retrourethral sling
|
Gozzi, C.
|
|
2008
|
47 |
9 |
p. 1224-1228
|
article
|
| 11 |
Die Methylierung des RASSF1A-Tumorsuppressorgenpromotors - Methylation of the RASSF1A tumor suppressor gene promoter
|
Serth, J.
|
|
2008
|
47 |
9 |
p. 1117-1121
|
article
|
| 12 |
EMMPRIN (CD147) - EMMPRIN (CD147)
|
Nawroth, R.
|
|
2008
|
47 |
9 |
p. 1152-1156
|
article
|
| 13 |
Entwicklung eines dreidimensionalen Prostatakarzinomzellkulturmodells - Development of a three-dimensional primary prostate cancer cell culture model
|
Jung, V.
|
|
2008
|
47 |
9 |
p. 1199-1204
|
article
|
| 14 |
Expression des „Corticotropin releasing faktor rezeptors 2“ (CRFR2) in der humanen Prostata - Expression of corticotropin releasing factor receptor 2 (CRFR2) in the human prostate
|
Tezval, H.
|
|
2008
|
47 |
9 |
p. 1079-1084
|
article
|
| 15 |
Geschlechtsspezifische Charakteristika und Prognose des Nierenzellkarzinoms - Gender-specific characteristics and survival of renal cell carcinoma
|
Schrader, A.J.
|
|
2008
|
47 |
9 |
p. 1182-1186
|
article
|
| 16 |
Identifizierung und Validierung klinisch relevanter molekularer Veränderungen im Prostatakarzinom - Identification and validation of clinically relevant molecular alterations in prostate cancer
|
Schlomm, T.
|
|
2008
|
47 |
9 |
p. 1193-1198
|
article
|
| 17 |
Immunstimulative CpG-Oligodeoxynukleotide (CpG-ODN) im orthotopen murinen Transitionalzellkarzinom (TCC)-Modell - Immunostimulatory CpG oligodeoxynucleotides (CpG-ODN) in an orthotopic murine transitional cell carcinoma (TCC) model
|
Olbert, P.J.
|
|
2008
|
47 |
9 |
p. 1133-1136
|
article
|
| 18 |
Intravesikale Therapie nicht muskelinvasiver Blasentumoren mit onkolytischen Vesikular-Stomatitisviren - Oncolytic vesicular stomatitis viruses as intravesical agents against non-muscle-invasive bladder cancer
|
Hadaschik, B.A.
|
|
2008
|
47 |
9 |
p. 1145-1151
|
article
|
| 19 |
Kalkulation einer neuen Untersuchungs- und Behandlungsmethode (NUB) - Calculating the price of a new diagnostic or therapeutic option
|
Burger, M.
|
|
2008
|
47 |
9 |
p. 1239-1244
|
article
|
| 20 |
Klinische Netzwerkstrukturen in der Uroonkologie - Clinical network structures in uro-oncology
|
Heidenreich, A.
|
|
2008
|
47 |
9 |
p. 1128-1132
|
article
|
| 21 |
Lasergestützte partielle Nephrektomie beim Nierenzellkarzinom - Laser-supported partial nephrectomy for renal cell carcinoma
|
Gruschwitz, T.
|
|
2008
|
47 |
9 |
p. 1173-1174
|
article
|
| 22 |
Minimal-invasive perkutane Nephrolitholapaxie (MIP) - Minimally invasive percutaneous nephrolitholapaxy (MIP)
|
Nagele, U.
|
|
2008
|
47 |
9 |
p. 1066-1073
|
article
|
| 23 |
Mitteilungen der DGU
|
|
|
2008
|
47 |
9 |
p. 1256-1267
|
article
|
| 24 |
Molekulare Charakterisierung der metastasierten Nierenzellkarzinome - Molecular characterization of metastatic renal cell carcinomas
|
Junker, K.
|
|
2008
|
47 |
9 |
p. 1187-1189
|
article
|
| 25 |
Molekulargenetische Marker des Prostatakarzinoms - Molecular genetic markers for prostate cancer
|
Schneider, S.
|
|
2008
|
47 |
9 |
p. 1208-1211
|
article
|
| 26 |
Molekular getriggerte Therapie des hormonrefraktären Prostatakarzinoms - Feasibility of targeted therapy based on immunohistochemical expression analysis in androgen-independent prostate cancer
|
Ohlmann, C.-H.
|
|
2008
|
47 |
9 |
p. 1218-1223
|
article
|
| 27 |
Muskelinvasives Urothelkarzinom der Harnblase - Muscle-invasive urothelial carcinoma of the bladder
|
Autenrieth, M.
|
|
2008
|
47 |
9 |
p. 1157-1161
|
article
|
| 28 |
Myofibroblasten und die afferente Signalverarbeitung in der Harnblase - Myofibroblasts and afferent signalling in the urinary bladder
|
Neuhaus, J.
|
|
2008
|
47 |
9 |
p. 1085-1090
|
article
|
| 29 |
Neuromuskuläre Funktionsstörungen des unteren Harntraktes jenseits von Querschnittlähmung und multipler Sklerose - Neuromuscular dysfunction of the lower urinary tract dysfunction beyond spinal cord injury and multiple sclerosis
|
Reitz, A.
|
|
2008
|
47 |
9 |
p. 1097-1105
|
article
|
| 30 |
Präklinische Studien zum Einfluss des Tyrosinkinaseinhibitors AEE788 auf die Malignität des Nierenzellkarzinoms - Preclinical studies on the influence of the tyrosine kinase inhibitor AEE788 on malignant properties of renal cell carcinoma cells
|
Wedel, S.A.
|
|
2008
|
47 |
9 |
p. 1175-1181
|
article
|
| 31 |
Prostatakarzinomforschung - Prostate cancer research
|
Ellinger, J.
|
|
2008
|
47 |
9 |
p. 1190-1192
|
article
|
| 32 |
Prostatakarzinomfrüherkennung in Deutschland - Early detection of prostate cancer in Germany
|
Sieverding, M.
|
|
2008
|
47 |
9 |
p. 1233-1238
|
article
|
| 33 |
Prävalenz von Lymphknotenmetastasen beim nicht muskelinvasiven Blasenkarzinom - Prevalence of lymph node metastases in non-muscle-invasive bladder cancer
|
Wiesner, C.
|
|
2008
|
47 |
9 |
p. 1162-1166
|
article
|
| 34 |
Stellenwert der Elastographie in der klinischen Diagnostik des lokalisierten Prostatakarzinoms - Impact of elastography in clinical diagnosis of prostate cancer
|
Eggert, T.
|
|
2008
|
47 |
9 |
p. 1212-1217
|
article
|
| 35 |
Strahlentherapie beim Prostatakarzinom - Radiotherapy in prostate cancer
|
Ganswindt, U.
|
|
2008
|
47 |
9 |
p. 1245-1255
|
article
|
| 36 |
TESE und M-TESE - TESE and mTESE
|
Weidner, W.
|
|
2008
|
47 |
9 |
p. 1106-1111
|
article
|
| 37 |
URO-Telegramm
|
|
|
2008
|
47 |
9 |
p. 1268
|
article
|
| 38 |
Von der Markerexpression zur individuellen Prognoseabschätzung urothelialer Neoplasien - From marker expression to individual therapy of patients with bladder cancer
|
Dorp, F. vom
|
|
2008
|
47 |
9 |
p. 1167-1170
|
article
|
| 39 |
Wissenschaftliche Fortentwicklung in der deutschsprachigen Urologie - Scientific advances in German-language research in urology
|
Rübben, H.
|
|
2008
|
47 |
9 |
p. 1065
|
article
|
| 40 |
Zur Therapie des fortgeschrittenen Peniskarzinoms - Treatment of advanced penile cancer
|
Protzel, C.
|
|
2008
|
47 |
9 |
p. 1229-1232
|
article
|
Journal description